Christopher Boerner
Chief Executive Officer chez BRISTOL-MYERS SQUIBB COMPANY
Fortune : 5 M $ au 31/03/2024
Profil
Christopher S.
Boerner is currently the Chairman & Chief Executive Officer at Bristol Myers Squibb Co. and also serves as a Director at Capital Health System, Inc. Previously, he held positions such as Marketing Director at Genentech, Inc., Independent Director at Achaogen, Inc., Vice President-Marketing at Dendreon Corp., and Executive Vice President-Commercial at Seagen Inc. He also worked as an Associate at McKinsey & Co., Inc. Dr. Boerner completed his undergraduate studies at Washington University in St. Louis and obtained graduate and doctorate degrees from the Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/03/2024 | 101 205 ( 0,01% ) | 5 M $ | 31/03/2024 |
Postes actifs de Christopher Boerner
| Sociétés | Poste | Début |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Executive Officer | 01/11/2023 |
Capital Health System, Inc.
 Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Capital Health System, Inc. owns and operates hospitals. It offers healthcare services in the areas of brain and spine, oncology, digestive health, orthopedics, gynecological surgery, heart and vascular, weight loss surgery, breast care, surgery, maternity, sleep medicine, chest pain, trauma and emergency, pediatrics, diabetes, and rehabilitation. The company was founded in December 1997 and is headquartered in Trenton, NJ. | Director/Board Member | - |
Anciens postes connus de Christopher Boerner
| Sociétés | Poste | Fin |
|---|---|---|
| ACHAOGEN | Director/Board Member | 10/06/2015 |
| SEAGEN INC. | Corporate Officer/Principal | 30/01/2015 |
| DENDREON CORPORATION | Sales & Marketing | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01/01/2010 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Formation de Christopher Boerner
| Washington University in St. Louis | Undergraduate Degree |
| Haas School of Business | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Capital Health System, Inc. owns and operates hospitals. It offers healthcare services in the areas of brain and spine, oncology, digestive health, orthopedics, gynecological surgery, heart and vascular, weight loss surgery, breast care, surgery, maternity, sleep medicine, chest pain, trauma and emergency, pediatrics, diabetes, and rehabilitation. The company was founded in December 1997 and is headquartered in Trenton, NJ. | Health Services |
